A Retrospective Review of Revaccination Patterns in Pediatric Hematopoietic Stem Cell Transplantation Recipients
- PMID: 37069829
- DOI: 10.1177/27527530221147861
A Retrospective Review of Revaccination Patterns in Pediatric Hematopoietic Stem Cell Transplantation Recipients
Abstract
Background: After a hematopoietic stem cell transplantation (HSCT), patients are left with little to no immunity to prevent infections. Importantly, this includes immunity gained from previous exposures, including vaccinations. This loss of immunity is a direct result of previous chemotherapy, radiation, and conditioning regimens the patients receive. It is critical to revaccinate patients post-HSCT to ensure protective immunity against vaccine-preventable diseases. Before 2017, all patients at our institution were referred to their pediatrician at approximately 12-month post-HSCT to be revaccinated. Clinical concern was raised at our institution regarding nonadherence and errors in vaccine schedules. Methods: To understand the magnitude of the problem with revaccination, we performed an internal audit of post-vaccine adherence in patients who received an HSCT between 2015 and 2017. A multidisciplinary team was developed to review the audit results and make recommendations. Results: This audit revealed delays in the initiation of the vaccine schedule, incomplete adherence to the recommended revaccination schedule, and errors in administration. Discussion: Based on the review of the data, the multidisciplinary team recommended an approach for systematic assessment of vaccine readiness and centralization of the administration of vaccines to be done within the stem cell transplant outpatient center.
Keywords: hematopoietic stem cell transplantation (HSCT); immunization; vaccination.
Similar articles
-
An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients: Revaccination Outcomes Following Pediatric HSCT.Transplant Cell Ther. 2021 Apr;27(4):317-326. doi: 10.1016/j.jtct.2021.01.017. Epub 2021 Jan 28. Transplant Cell Ther. 2021. PMID: 33836875
-
Adherence and immune response to revaccination following hematopoietic stem cell transplantation at a pediatric onco-hematology reference center.Transpl Infect Dis. 2018 Aug;20(4):e12903. doi: 10.1111/tid.12903. Epub 2018 May 7. Transpl Infect Dis. 2018. PMID: 29668078
-
Associations Between Demographic Factors, Clinical Variables, Social Determinants of Health, Vaccine Hesitancy, Vaccine Behavior, and Revaccination Status: A Survey of Adult HCT Survivors in the United States.Transplant Cell Ther. 2024 Dec;30(12):1221.e1-1221.e13. doi: 10.1016/j.jtct.2024.09.012. Epub 2024 Sep 19. Transplant Cell Ther. 2024. PMID: 39303986
-
[Vaccination].Klin Padiatr. 2001 Sep;213 Suppl 1:A77-83. doi: 10.1055/s-2001-17503. Klin Padiatr. 2001. PMID: 11577366 Review. German.
-
Long-term pneumococcal vaccine immunogenicity following allogeneic hematopoietic stem cell transplantation.Vaccine. 2019 Jan 14;37(3):510-515. doi: 10.1016/j.vaccine.2018.11.053. Epub 2018 Nov 27. Vaccine. 2019. PMID: 30502071
Cited by
-
Quality Improvement Initiative to Improve Time and Adherence to Revaccination after Hematopoietic Cell Transplantation: Implementation of a Revaccination Clinic within the Transplantation Program.Transplant Cell Ther. 2023 Oct;29(10):635.e1-635.e8. doi: 10.1016/j.jtct.2023.07.020. Epub 2023 Jul 28. Transplant Cell Ther. 2023. PMID: 37517611 Free PMC article.
-
Supportive Care in Pediatric Oncology: Opportunities and Future Directions.Cancers (Basel). 2023 Nov 23;15(23):5549. doi: 10.3390/cancers15235549. Cancers (Basel). 2023. PMID: 38067252 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources